Andrea Heslin Smiley

Andrea Heslin Smiley will serve on the respective Audit and Compensation Committees.

An accomplished Life Sciences industry executive, Andi has 28 years of commercialization and general management experience across numerous senior leadership roles in both public and private companies.

Currently, she is the President and CEO of VMS BioMarketing, a high-growth, healthcare services business working to improve patient outcomes by delivering evidence-based engagements to patients, caregivers, and healthcare providers through a technology-enabled, data-driven, clinical educator platform.

Having spent 18 years at Eli Lilly and Company in various business unit leadership roles as well as in management positions across finance, business development, corporate affairs, and brand management, Andi brings a wealth of experience in numerous therapeutic areas, deep insight on the patient and provider mindset and extensive knowledge on how to drive sustainable behavior change that enables improvements in medication adherence.

Beyond her work at VMS, Andi currently serves on the board of directors of Rockwell Medical and is an Advisor for Agent Capital, a leading healthcare venture capital firm. She previously served on Assertio Therapeutics, Zyla Life Sciences, Egalet Corporation, and AppianRx. Additionally, she serves on the board of the Indiana Alzheimer’s Association and the Mitch Daniels Leadership Foundation.

Prior to Eli Lilly and Company, Andi worked as a management consultant for Putnam Associates, where she advised brands in the biotech and pharmaceutical, and managed healthcare fields on product launches and access strategies. She earned her BA in economics from DePauw University where she was an Honors Management Fellow.